NextCell Pharma Dividends and Buybacks

Dividend criteria checks 0/6

NextCell Pharma does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-31.2%

Buyback Yield

Total Shareholder Yield-31.2%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

We Think NextCell Pharma (STO:NXTCL) Needs To Drive Business Growth Carefully

Mar 09
We Think NextCell Pharma (STO:NXTCL) Needs To Drive Business Growth Carefully

We're Not Very Worried About NextCell Pharma's (STO:NXTCL) Cash Burn Rate

Oct 07
We're Not Very Worried About NextCell Pharma's (STO:NXTCL) Cash Burn Rate

NextCell Pharma (STO:NXTCL) Is In A Good Position To Deliver On Growth Plans

May 23
NextCell Pharma (STO:NXTCL) Is In A Good Position To Deliver On Growth Plans

NextCell Pharma (STO:NXTCL) Is In A Good Position To Deliver On Growth Plans

Feb 01
NextCell Pharma (STO:NXTCL) Is In A Good Position To Deliver On Growth Plans

We Think NextCell Pharma (STO:NXTCL) Can Afford To Drive Business Growth

Sep 21
We Think NextCell Pharma (STO:NXTCL) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About NextCell Pharma's (STO:NXTCL) Cash Burn Situation

May 31
Here's Why We're Not Too Worried About NextCell Pharma's (STO:NXTCL) Cash Burn Situation

We Think NextCell Pharma (STO:NXTCL) Needs To Drive Business Growth Carefully

Feb 15
We Think NextCell Pharma (STO:NXTCL) Needs To Drive Business Growth Carefully

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if NXTCL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NXTCL's dividend payments have been increasing.


Dividend Yield vs Market

NextCell Pharma Dividend Yield vs Market
How does NXTCL dividend yield compare to the market?
SegmentDividend Yield
Company (NXTCL)n/a
Market Bottom 25% (SE)1.6%
Market Top 25% (SE)4.8%
Industry Average (Biotechs)1.6%
Analyst forecast (NXTCL) (up to 3 years)n/a

Notable Dividend: Unable to evaluate NXTCL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NXTCL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate NXTCL's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as NXTCL has not reported any payouts.


Discover strong dividend paying companies